Here is the top of page
Kyowa Kirin aims to contribute to the health and comfort of people around the world.
Our mission is to respond to the needs of patients suffering from diseases for which no effective treatments are available, their families and the healthcare professionals fighting those diseases on the front line.
Specialising in the core fields of oncology, nephrology, immunology / allergy and the central nervous system, we develop leading-edge biotechnologies, focussing on the use of antibodies, to develop and discover innovative new drugs, which Kyowa Kirin market worldwide.
As a global company, we must earn the trust of society by excelling in our social responsibilities. We work to
maintain transparency, fairness, compliance and co-existence with our local communities.
Our vision is to be a global specialty pharmaceutical company, contributing to human health and wellbeing worldwide through innovative drug discovery and global commercialisation.
This work will be driven by leading-edge antibody technologies in the core therapeutic areas of oncology, nephrology, immunology/allergy and the central nervous system. We are currently focussing on launching pipeline products originated by Kyowa Kirin in Europe and the United States.